Organon has announced the completion of its acquisition of Dermavant Sciences from Roivant, a deal first reported in September 2024. The completion comes at a strategic time, as the FDA reviews VTAMA cream’s potential expansion into atopic dermatitis treatment, with a decision expected in Q4 2024. VTAMA (tapinarof) cream, 1%, Dermavant’s flagship product, represents a unique addition to Organon’s portfolio as a…
DeepHealth has announced its acquisition of UK-based Kheiron Medical Technologies, marking a significant consolidation in the AI-powered breast cancer screening space. The acquisition brings together DeepHealth’s Smart Mammo platform with Kheiron’s Mia (Mammography Intelligent Assessment) suite of solutions. The move appears strategically timed as AI continues to gain traction in medical imaging, particularly in mammography where radiologist shortages and increasing screening volumes…
Hologic, a medtech company focused on women’s health, has announced a definitive agreement to acquire Gynesonics, a privately held medical device company. The acquisition is valued at approximately $350 million, subject to working capital and other customary closing adjustments. Gynesonics is known for developing the Sonata System, designed for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those…
Pomelo Care has announced its acquisition of The Doula Network, the largest network of credentialed doulas in the United States. This acquisition positions Pomelo as the only maternity care model to offer both virtual and in-person services throughout the U.S. The Doula Network is recognized for its substantial in-network support with major commercial and Medicaid plans. The acquisition comes at a time…
Organon has announced its plans to acquire Dermavant Sciences, a Roivant company focused on innovative immuno-dermatology treatments. The deal, which is expected to be finalized in the fourth quarter of 2024, will allow Organon to expand its dermatology offerings in the U.S. market, particularly with Dermavant’s flagship product, VTAMA (tapinarof) cream, 1%. VTAMA cream, a novel, non-steroidal topical therapy, was approved by…
ŌURA, the company behind the Oura Ring, a smart ring providing personalized health data, insights, and guidance, has announced the acquisition of Finnish personalized metabolic health company, Veri. Veri, which partners with continuous glucose monitors (CGM) to guide users toward healthier habits, will bring its expertise in metabolic health to ŌURA, with a significant portion of Veri’s team, including its three founders,…
Sonio, the medtech company specializing in women’s and children’s health, has officially been acquired by Samsung Medison, a global medical equipment company affiliated with Samsung Electronics, following the approval of the French Ministry of the Economy and Finance. This acquisition marks a significant milestone in the global expansion of Sonio’s innovative healthcare solutions, aimed at enhancing maternal and child health worldwide. The acquisition…
WellSpring Consumer Healthcare, a developer and marketer of over-the-counter (OTC) and personal care brands, has announced the acquisition of vH essentials from Wisconsin Pharmacal Company. The financial terms of the transaction were not disclosed. This acquisition marks a another step for WellSpring, which is backed by Avista Healthcare Partners, a middle-market healthcare private equity firm known for building growth-oriented healthcare businesses. vH…
